The Japanese drugmaker said that Kim, president of its U.S. business unit, will succeed Chief Executive Christophe Weber, who plans to retire in June next year.

CARLSBAD, Calif. - Tyra Biosciences , Inc. (NASDAQ:TYRA), a biotech firm specializing in precision medicines targeting Fibroblast Growth Factor Receptor (FGFR) biology, today announced the appointment ...

The Food & Drug Administration (FDA), has quietly taken down their guidance detailing diversity action plans for clinical ...

The aggregate gross proceeds to the Company from the offering are expected to be $1.043 million, before deducting the placement agent fees and other offering expenses payable by the Company. The ...

The pharmaceutical industry is on the verge of a significant transformation due to the emergence of artificial intelligence ...

Study urges industry to be more transparent and fairer in selecting speakers, and to recruit more women to steering ...

Analyst Patrick Trucchio from H.C. Wainwright reiterated a Buy rating on Milestone Pharmaceuticals (MIST – Research Report) and keeping the ...

The two largest leases in Boston-Cambridge's life science market went to Korro Bio and Ultragenyx Pharmaceuticals, which ...

Kassa and others said Big Pharma continues to invest even as private equity funds have pulled back. He noted ...

Beachwood City Council appointed Peter Smith to serve as its newest member at its Jan. 21 meeting at Beachwood City Hall.

Women, youth, farmers and poor can continue to be Budget 2025's ‘roti, kapda aur makan’ Modi govt has a key task in Budget 2025: Unlocking the PLI goldmine The role has been opened for internal ...